Shareholder alert: pomerantz law firm investigates claims on behalf of investors of sonoma pharmaceuticals, inc. – snoa

New york, nov. 30, 2020 (globe newswire) -- pomerantz llp is investigating claims on behalf of investors of sonoma pharmaceuticals, inc. (“sonoma” or the “company”) (nasdaq: snoa). such investors are advised to contact robert s. willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

SNOA Ratings Summary

SNOA Quant Ranking